Matricelf Ltd (TLV:MTLF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 231.00
+3.90 (1.72%)
Apr 29, 2026, 10:00 AM IDT
Matricelf Market Cap
Matricelf has a market cap or net worth of 66.41 million as of April 28, 2026. Its market cap has increased by 31.11% in one year.
Market Cap
66.41M
Enterprise Value
46.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
231.00
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 66.41M, an increase of 7.13%. That is a compound annual growth rate of 1.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 66.41M | -56.29% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clal Biotechnology Industries | 52.70M |
| BioLineRx | 33.94M |
| Evogene | 29.63M |
| Geffen Residence & Renewal | 270.51M |
| BioLight Life Sciences | 22.38M |
| Can-Fite BioPharma | 20.77M |
| XTL Biopharmaceuticals | 18.92M |
| Purple Biotech | 18.59M |